Dina Masi
CIK 1345281 · Chief Financial Officer · last filed 2025-12-10
Dina Masi is a Chief Financial Officer who has filed 13 SEC Form 4 insider transactions across 1 company since 2007.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
13
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INTEGRATED BIOPHARMA INC (INBP) Delisted | Chief Financial Officer | 0 | — | — | $0 | 1 | 2007-02-15 |
Recent Filings
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-10 | — | Grant (A) | — | $0 | |
| 2025-05-22 | — | Mixed | +135,000 | $12.2K | |
| 2024-12-05 | — | Grant (A) | — | $0 | |
| 2024-11-25 | — | Mixed | +65,000 | $5.8K | |
| 2023-11-29 | — | Grant (A) | — | $0 | |
| 2023-09-21 | — | Mixed | +50,000 | $4.5K | |
| 2022-11-10 | — | Grant (A) | — | $0 | |
| 2021-11-03 | — | Grant (A) | — | $0 | |
| 2020-11-20 | — | Grant (A) | — | $0 | |
| 2019-05-29 | — | Grant (A) | — | $0 |
Showing 1–10 of 13
Page 1 of 2
Next
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.